StoneX completes acquisition of R.J. O'Brien to become largest non-bank FCM

StoneX Group Inc. (NASDAQ:SNEX) has completed its acquisition of R.J. O’Brien, positioning StoneX as the largest non-bank Futures Commission Merchant in the U.S. and significantly expanding its global derivatives footprint. This strategic acquisition adds RJO's $766 million in revenue, $170 million in EBITDA, and nearly $6 billion in client float, with StoneX targeting $50 million in expense savings and expecting enhanced margins and accretive earnings. The acquisition underscores StoneX's aggressive growth strategy, which also includes strong Q2 2025 earnings, additional planned acquisitions, and a recent $625 million bond offering, leading Jefferies to raise its price target to $102.

Analysis

StoneX Group Inc. (SNEX) has solidified its position as the largest non-bank Futures Commission Merchant in the United States by completing its acquisition of R.J. O’Brien (RJO). This strategic transaction is immediately impactful, incorporating RJO's substantial $766 million in annual revenue, approximately $170 million in EBITDA, and nearly $6 billion in client float into StoneX's operations. Management has outlined clear synergy targets, aiming for $50 million in expense savings and at least $50 million in capital synergies, with the acquisition expected to be accretive to earnings and enhance both margins and return on equity. This move is part of a broader, aggressive growth strategy, evidenced by a recent letter of intent to acquire Intercam and a planned purchase of French brokerage Plantureux et Associés. The company's recent performance underpins this expansion, with fiscal Q2 2025 earnings of $1.41 per share surpassing Jefferies' estimate of $1.26, driven by outperformance in its Commercial and Institutional segments. To finance this growth, StoneX has priced $625 million in senior secured notes. Despite the positive operational momentum and a Jefferies price target increase to $102, the company's stock is trading near its 52-week high after a 76% surge over the past year, and an external analysis cited in the article suggests it may be slightly overvalued at current levels.

Key Decisions for Investors

• Given the successful R.J. O'Brien acquisition, strong Q2 earnings beat, and clear expansion strategy, investors may view the current developments as supportive of the bullish thesis, which is further validated by Jefferies' price target upgrade to $102.
• Investors should closely monitor the integration of R.J. O'Brien in subsequent quarters, specifically tracking progress toward the targeted $100 million in combined cost and capital synergies, as successful execution is critical to justifying the acquisition's value.
• Caution is warranted regarding the current valuation, as the stock trades near its 52-week high following a 76% annual gain and is flagged as potentially overvalued, suggesting that disciplined entry points may be more prudent than chasing the current momentum.
• The use of significant debt, including $625 million in new notes, to fund this M&A-driven growth strategy requires investors to assess the company's leverage and its ability to manage interest expenses while pursuing further acquisitions.